Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 10
Submit an article Journal homepage
121
Views
37
CrossRef citations to date
0
Altmetric
Research Article

Fixed-dose Pegfilgrastim is Safe and Allows Neutrophil Recovery in Patients with Non-Hodgkin's Lymphoma

S. George Cancer and Blood Institute of the Desert, 39700 Bob Hope Drive, Suite 110 Rancho Mirage, CA 92270-7103, USA
,
F. Yunus Boston baskin Cancer Group, 1331 Union Avenue, Suite 800, Memphis, TN 38104-3513, USA
,
D. Case Maine Center for Cancer Medicine, 100 US Route 1, Unit 108, Scarborough, ME 04074-9308, USA
,
B.-B. Yang Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91230-1799, USA
,
J. Hackett Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91230-1799, USA
,
J. E. Shogan Oncology-Hematology Association, 580 South Aiken Avenue, Suite 110, Pittsburgh, PA 15232, USA
,
L.A. Meza Southwest Oncology Associates, 443 Heyman Blvd, Suite A, Layafette, LA 70503, USA
,
T. A. Neumann Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91230-1799, USA
&
B. C. Liang Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91230-1799, USA
 show all
Pages 1691-1696 | Published online: 16 Nov 2010

References

  • McKenna, P.J., Korach, E. and Andresen, J. "Filgrastim-SD, a sustained duration form of filgrastim, (rhuG-CSF) has similar effects on neutrophil function compared to filgrastim", Blood 92, 379a, (abstract).
  • Holmes, F.A., 0°Shaughnessy, Vukelja, S., Jones, S.E., Shogan, J., Savin, M., Glaspy, J., Moore, M., Meza, L., Wiznitzer, I., Neumann, T.A., Hill, L.R. and Liang, B.C. (2002) "Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage IT or stage llUIV breast cancer", Journal of Clinical Oncology 20, 727–731.
  • Green, M.D., Koelbl, H., Baselga, J., Galid, A., Guillem, V., Gascon, P., Siena, S., Lalisang, RI., Samonigg, H., Clemens, M.R., Zani, V, Liang, B.C., Renwick, J. and Piccart, M.J. (2003) "A randomized, double-blind, multicenter, phase 3 study of fixed-dose, single-administration pegfilgrastim vs daily filgrastim in patients receiving myelosuppressive chemotherapy". Annals of Oncology 14, 29–35.
  • Clopper, C.J. and Pearson, E. (1934) "The use of confidence or fiducial limits illustrated in the case of binomial", Biometrika 26, 404–413.
  • Fisher, R.I., Gaynor, E.R., Dahlberg, S., Oken, M.M., Grogan, T.M., Mize, E.M., Glick, J.H., Coltman, Jr., C.A. and Miller, T.P. (1994) "A phase M comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study", Annals of Oncology 5, 91–95.
  • Campbell, C., Sawka, C., Franssen, E. and Bernstein, N.L. (1999) "Delivery of full dose CHOP chemotherapy to elderly patients with aggressive non-Hodgkin's lymphoma without G-CSF support", Leukemia and Lymphoma 35, 119–127.
  • Morrison, V.A., Picozzi, V., Scott, S., Pohlman, B., Dickman, E., Lee, M., Lawless, G., Kerr, R., Caggiano, V., Delgado, D., Fridman, M., Ford, J. and Carter, W.B. (2001) "The impact of age on delivered dose intensity and hospitalizations for febrile neutropenia in patients with intermediate-grade non-Hodgkin's lymphoma receiving initial CHOP chemotherapy: a risk factor analysis", Clinical Lymphoma 2,47–56.
  • Czuczman, M., Grillo-Lopez, A.J., White, C.A., Saleh, M., Gordon, L., LoBuglio, A.F., Jonas, C., Alkuzweny, B. and Dowden, S. (1999) "Rituximab/CHOP chemotherapy inpatients (PTS) with low grade lymphoma (LG/F NHL): Progression free survival after 3 years (median) follow-up", Blood 94, 99a, (abstract).
  • Vose, EM., Link, B.K., Grossbard, R.I., Fisher, RI., Czuczman, M., Grillo-Lopez, A., Gilman, P., Lowe, A. and Kunkel, L.A. (1999) "Phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated intermediate or high-grade nonHodgkin's lymphoma (HL)", Blood 94, 89a, (abstract).
  • Gianni, A.M., Bregni, M., Siena, S., Brambilla, C., Di Nicola, M., Lombardi, E, Gandola, L., Tarella, C., Pileri, A., Ravagnani, F., Valagussa, P., Bonadonna, G., Stern, A.C., Magni, M. and Caracciolo, D. (1997) "High-dose chemotherapy and autologous bone marrow transplantation compared with IVIACOP-B in aggressive B-cell lymphoma", New England Journal of Medicine 336, 1290–1297.
  • Attal, M., Harousseau, J.L., Sotto, J.J., Fuzibet, J.G., Rossi, J.F., Casassus, P., Maisonneuve, H., Facon, T., Ifrah, N., Payen, C. and Bataille, R. (1996) "A prospective, randomized trial of autologous bone marrow transplantation and chemotherpy in multiple myeloma". New England Journal of Medicine 335, 91–97.
  • Epelbaum, R., Haim, N., Ben-Shahar, M., Ron, Y. and Cohen, Y. (1998) "Dose-intensity analysis for CHOP chemotherapy in diffuse aggressive large cell lymphoma", Israel Journal of Medical Sciences 24, 533–538.
  • Johnston, E., Crawford, J., Blackwell, S., I3jurstrom, T., Lockbaum, P., Roskos, L., Yang, B.-B., Gardner, S., Miller-Messana, M.A., Shoemaker, D., Garst, J. and Schwab, G. (2000) "Randomized, dose-escalation study of SD/01 compared with daily filgrastim in patients receiving chemotherapy", Journal of Clinical Oncology 18, 2522–2528.
  • Molineux, G., Kinstler, 0., Briddell, B., Hartley, C., McElroy, P., Kerzic, P., Sutherland, W., Stoney, G., Kern, B., Fletcher, F.A., Cohen, A., Korach, E., Ulich, T., McNiece, I., Lockbaum, P., Miller-Messana, MA., Gardner, S., Hunt, T. and Schwab, G. (1999) "A new form of filgrastim with sustained duration in vivo and enhanced ability to mobilize PB1PC in both mice and humans", Experimental Hematology 27, 1724–1734.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.